Proove Biosciences has a total of 22 patents globally, out of which 2 have been granted. The United States of America is where Proove Biosciences has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Proove Biosciences.
Proove Biosciences was founded in 2009. Proove Biosciences provides services related to biotechnology. The company provides dosage services, laboratory testing, medical support, and clinical research.
Do read about some of the most popular patents of Proove Biosciences which have been covered by us in this article and also you can find Proove Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Proove Biosciences patent portfolio.
How many patents does Proove Biosciences have?
Proove Biosciences has a total of 22 patents globally. These patents belong to 12 unique patent families.
How Many Patents did Proove Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Proove Biosciences Applications Filed | Proove Biosciences Patents Granted |
| 2016 | 12 | – |
| 2015 | 1 | – |
| 2014 | – | 2 |
| 2013 | 4 | – |
| 2012 | 1 | – |
| 2011 | 4 | – |
How many Proove Biosciences patents are Alive/Dead?
All the Proove Biosciences patents are dead.
How Many Patents did Proove Biosciences File in Different Countries?
Countries in which Proove Biosciences Filed Patents
| Country | Patent |
| United States Of America | 12 |
| Europe | 1 |
| Japan | 1 |
Where are Research Centers of Proove Biosciences Patents Located?
The Research Centers of ProoveBiosciences Patents is the United States of America.
10 Best Proove Biosciences Patents
US20140378351A1 is the most popular patent in the Proove Biosciences portfolio. It has received 12 citations so far from companies like Genemarkers, Shengxiang Biotechnology.
Below is the list of 10 most cited patents of Proove Biosciences:
| Publication Number | Citation Count |
| US20140378351A1 | 12 |
| WO2016176519A1 | 8 |
| WO2011126910A2 | 8 |
| US20190055603A1 | 5 |
| US20180137235A1 | 5 |
| US20180322960A1 | 4 |
| WO2016176474A1 | 3 |
| US20150119297A1 | 2 |
| US8716349B2 | 1 |
| US8716350B2 | 1 |
What Percentage of Proove Biosciences US Patent Applications Were Granted?
Proove Biosciences (Excluding its subsidiaries) has filed 10 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0%.
Below are the key stats of Proove Biosciences patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Proove Biosciences?
| Law Firm | Total Applications | Success Rate |
| Dorsey & Whitney Llp | 8 | 0% |
| Patrick R Delaney Esq | 2 | 0% |
List of Proove Biosciences patents
| Proove Biosciences Patents | Title |
| US20140378351A1 | Compositions And Methods For The Treatment Of Somatosensory Disorders |
| WO2016176519A1 | Compositions And Methods For The Treatment Of Somatosensory Disorders |
| WO2011126910A2 | System And Method For Processing Genotype Information Relating To Opioid Response |
| US20190055603A1 | System And Method For Processing Genotype Information Relating To Drug Metabolism |
| US20180137235A1 | System And Method For Processing Genotype Information Relating To Medically-Assisted Treatment Regarding Withdrawal Or Pain |
| US20180322960A1 | System And Method For Processing Genotype Information Relating To Nsaid Risk |
| WO2016176474A1 | System And Method For Processing Genotype Information Relating To Non-Opioid Response |
| US20150119297A1 | System And Method For Processing Genotype Information Relating To Opioid Risk |
| US8716349B2 | System And Method For Processing Genotype Information Relating To Pain Perception |
| US8716350B2 | System And Method For Performing Medical Research |
| US20150310164A1 | System And Method For Processing Genotype Information Relating To Drug Metabolism |
| WO2016176458A1 | System And Method For Processing Genotype Information Relating To Treatment With Pain Medication |
| US20190080048A1 | Compositions And Methods For The Treatment Of Somatosensory Disorders |
| US20190018923A1 | System And Method For Processing Genotype Information Relating To Opioid Response |
| US20180247013A1 | System And Method For Processing Genotype Information Relating To Nsaid Risk |
| US20150161358A1 | System And Method For Processing Genotype Information Relating To Opiod Risk |
| EP2552433A4 | System And Method For Processing Genotype Information Relating To Non-Opioid Response |
| WO2016176475A3 | System And Method For Processing Genotype Information Relating To Medically-Assisted Treatment Regarding Withdrawal Or Pain |
| WO2016176451A3 | System And Method For Processing Genotype Information Relating To Drug Metabolism |
| WO2016176482A1 | Mu-Opioid Receptor Binding Compounds |
| WO2012166891A3 | Compositions And Methods For The Treatment Of Somatosensory Disorders |
| JP2013523764A5 | Compositions And Methods For Treating Somatosensory Disorders |
What are Proove Biosciences key innovation segments?
What Technologies are Covered by Proove Biosciences?
The chart below distributes patents filed by Proove Biosciences